|
Video: What is a Stock Split?
|
|
Adaptimmune Therapeutics is a biopharmaceutical company focused on developing T-cell therapies for solid tumors. Co.'s proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables it to identify cancer targets, find and genetically engineer T-cell receptors against those targets, and produce therapeutic candidates (SPEAR T-cells) for administration to patients. Co. has clinical trials on its ADP-A2M4, ADP-A2M4CD8, each targeting the MAGE-A4 antigen, and ADP-A2AFP SPEAR T-cells targeting the alpha fetoprotein (AFP) cancer antigen in solid tumor types including non-small cell lung cancer, head and neck cancer, ovarian, urothelial, melanoma, and hepatocellular. According to our ADAP split history records, Adaptimmune Therapeutics PLC has had 1 split. | |
|
Adaptimmune Therapeutics PLC (ADAP) has 1 split in our ADAP split history database. The split for ADAP took place on March 31, 2000. This was a 2 for 1
split, meaning for each share of ADAP owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.
When a company such as Adaptimmune Therapeutics PLC splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the ADAP split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adaptimmune Therapeutics PLC shares, starting with a $10,000 purchase of ADAP, presented on a split-history-adjusted basis factoring in the complete ADAP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/07/2015 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$17.23 |
|
End price/share: |
$1.58 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-90.83% |
|
Average Annual Total Return: |
-23.55% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$916.68 |
|
Years: |
8.90 |
|
|
|
Date |
Ratio |
03/31/2000 | 2 for 1
|
|
|